Cdrh digital transformation services data modernization and governance. For these reasons, cdrh requires outside expertise with the hiring of a subject matter expert who shall provide services to…

Ended Awarded Last action

Contract number
75F40119F19054
Awardee
Awarding agency
Obligated
$1,099,561

Award facts

Contract value 85% obligated
  • $1,099,560.77 Current, with exercised options
  • $1,294,618.49 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Time and Materials
Place of performance
Reston, VA 20190, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00005 -$25,536
Exercise an Option P00004 $191,888
Supplemental Agreement for work within scope P00003 $0
Exercise an Option P00001 $377,548
Supplemental Agreement for work within scope P00002 $0
Original award $555,661

About this award

The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) call to Brillient Corporation, a Minority-Owned Business and Subchapter S Corporation, to provide Digital Transformation Services, Data Modernization, and Governance support for the Center for Devices and Radiological Health (CDRH) at the FDA. The contract has a potential value of $1,294,618.49 and a completion date of April 30, 2023. This BPA call is part of the Professional Services Schedule (PSS) contract vehicle, which allows federal agencies to acquire a wide range of professional services. Brillient, as the prime contractor, will provide leadership, business acumen, and expertise in data modernization and governance to support CDRH's business transformation initiatives, including TPLC and MORM modeling.

Description

Cdrh digital transformation services data modernization and governance. For these reasons, cdrh requires outside expertise with the hiring of a subject matter expert who shall provide services to include leadership, business acumen, and data modernization and governance to navigate through the dynamic cdrh business transformation roadmap and tplc and morm modeling currently underway.

Quick answers

Who was awarded contract 75F40119F19054?

75F40119F19054 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on April 30, 2019.

How much is contract 75F40119F19054 worth?

The government has obligated $1,099,561 on 75F40119F19054. Its potential value, with all options, is $1,294,618.

Is contract 75F40119F19054 an order under another contract?

Yes. 75F40119F19054 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on The Professional Services Schedule (PSS).

Was contract 75F40119F19054 competed?

The extent of competition for 75F40119F19054 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award